Background macular Shape Background macular Shape Background macular Shape
Grants > Retinal Stem Cells for Transplantation in Macular Degeneration Updated On: Jan. 23, 2025
Macular Degeneration Research Grant

Retinal Stem Cells for Transplantation in Macular Degeneration

Derek van der Kooy, PhD

Principal Investigator

Derek Van Der Kooy, PhD

University of Toronto

Toronto, Ontario, Canada

About the Research Project

Program

Macular Degeneration Research

Award Type

Standard

Award Amount

$100,000

Active Dates

April 01, 2008 - March 31, 2010

Grant ID

M2008013

Goals

In this study, the researchers will isolate mouse adult retinal stem cells and enrich them for cone photoreceptors by manipulating specific cellular pathways as through a cell sorting technique. They will also test the ability of transplanted adult retinal stem cells to restore vision in mice that lack functioning cone photoreceptors.

Summary

Normal vision relies on the function of cells called cone photoreceptors and retinal pigment epithelial cells. In patients with AMD these cells die. Current treatments are effective in slowing down AMD, but they do not reverse the degeneration that has already occurred. To restore normal vision, these lost cells will need to be replaced. Stem cell therapy offers the promise of an inexhaustible supply of retinal cells that can be used for transplant into eyes affected by AMD. These researchers have shown that isolated retinal stem cells can generate cone photoreceptors and retinal pigment epithelial cells. When these retinal stem cells are transplanted into mouse eyes, they are able to integrate into the host retina and develop correctly.